As is well known, matrix metalloproteinases (MMP), matrix metalloproteinase inhibitors (TIMP), tissue-type plasminogen activator (TPA), and urokinase-type plasminogen activator (UPA) play a crucial role in cancer invasion and progression [37]. Here, PLAU is linked to cancer.